The Longevity and DeSci Recap is back, and our latest edition covers high-profile events including the Longevity Investors Conference in Gstaad, new innovations in AFib monitoring, and even some celebrity-related news. This month, we’ll continue to explore the latest events, current research, and investment news to give you a complete round-up of the current landscape of longevity and decentralized science (DeSci).
Upcoming conferences and events
11th session of the Aging Research and Drug Discovery Meeting
On the 26th and 30th of this month, you can join Nir Barzilai, Vera Gorbunova, Aubrey de Grey and a host of other industry names at the 11th edition of the Aging Research and Drug Discovery Meeting. In this long-awaited event, participants will discuss interventions for age-related diseases, longevity, and so much more.
Gstaad, Switzerland plays host to the most exclusive event of the year
Once a year, the world’s longevity elite, including top investors, meet in Switzerland to discuss market movements and pave the way for the industry’s future. This year’s event is no exception and is set to be a captivating networking experience. Attendees are carefully chosen, with all investors welcome to apply for tickets here.
HLTH 2024: health is back on stage in Vegas
It’s lights, cameras, action as the US edition of the HLTH 2024 conference hits the stage in Las Vegas. Like previous years, this is set to be one of the biggest events in healthcare and will cover topics such as AI in healthcare, longevity, and marketing. Speakers are set to include Johnson & Johnson CEO Joaquin Duato, Vice President of Healthcare and Life Sciences at NVIDIA Kimberly Powell, Cleveland Clinic CEO Tom Mihaljevic, and many more speakers combining healthcare with technology on a whole new level. Tickets for the event are still available online.
Tech breakthroughs & new research
Heart health could be just a ring away
Smart watches have long been upgraded to have new health-monitoring features, but this isn’t the only way to track vitals. Ultrahuman’s team has started designing a new wearable solution for heart monitoring: a simple ring. Now the company has secured a massive $35 million in funding to follow this project and have launched a solution called ‘PowerPlugs’. Among this batch is a plugin designed to catch atrial fibrillation, which occurs in 12.2 million people in the US.
TruDiagnostic turns reality TV
At Lifespan.io, it’s not often we get to discuss the world of celebrity, but this month, two have caught our eye: Bryan Johnson and Kim Kardashian. However, it’s not all glamor. Kim and her reality-tv family took a longevity test to assess epigenetic markers related to aging. According to the results, TV’s most famous family ended up looking, feeling, and being younger than their biological age. This had sparked a renewed interest in the field and its future potential.
DAOs and communities
VitaDAO’s community joined in for a data drop by Artan Bio
As part of VitaDAO’s ongoing collaborations, the biotech DAO hosted an event to unveil data from VitaRNA by Artan Bio. This marks a major milestone in longevity research and offers a boost to the longevity community. At this event, participants were able to learn insights into gene therapies and discover ways to target aging while engaging directly with researchers.
$BIO tokens to drop on this August
Bio.xyz announced on its Twitter that on August 8th, the DAO’s signature $BIO token will launch live. This will mark the opportunity for the DAO’s supporters and token holders to exchange their bioDAO tokens, among others, for $BIO in a genesis swap.
VitaDAO celebrates its 3rd birthday, marking a new wave in DeSci
Three years ago, VitaDAO, one of the first longevity DAOs, was formed, marking a shift in the scientific world. As the community passes this significant milestone, it’s time to acknowledge its achievements, as this DAO has evaluated 200+ longevity projects, funded 23, and allocated over $4.5 million in funding, all while paving the way for those who come next. This biotech DAO is also noted as being the 2nd DAO most worth investing in on Tracxn.
Other DeSci and longevity news
$15 million for Oisín Biotechnologies’ longevity pharma project
Age-related fragility is said to affect as many as 17% of older adults in the US today. Oisín Biotechnologies is seeking out a solution. Having just acquired $15 million in Series A funding led by AbbVie Ventures, the biotech is developing pharmaceutical solutions for frailty by improving muscle mass and eliminating unwanted fat cells to improve human healthspan.
$400 million funding investment for the Hevolution Foundation
The longevity investment branch has just announced that it will invest over $400 million in healthcare. This move would make it one of the largest philanthropic contributors in geroscience, giving it the potential to impact the lives of others, including programs to support researchers’ interest in aging globally and particularly in Latin America.
Michael J. Fox Foundation awards $6 million grant to Lario Therapeutics
Biopharmaceutical company Lario Therapeutics has just secured a grant of $6 million to pursue precision medicines for neurological conditions. The company says that the latest funding will go towards preclinical research on Lario’s CaV2.3 calcium channel inhibitors and the protection that they could potentially offer against Parkinson’s disease, among others.
Social media pages to follow this month
Niklas Anzinger — CEO of Vitalia and founder of Infinita VC. Follow for longevity and investment-related posts.
Bryan Johnson — This month, our very own Arkadi Mazin gave his take on Bryan Johnson’s blueprint of longevity. Now it’s time to follow directly to learn the latest.
Foresight Institute — Offers some of the latest investment news in the longevity sector worldwide.
